Maxipolyposis, i.e. severe, diffuse nasosinusal polyposis, is generally treated with an onerous surgery. Therefore, recurrence, roughly rangling from 15% to 25%, are quite a disagreable outcome which is to be minimized. To this purpose, it may be useful to differentiate the residual from the recurrent polyposis, as is usually done in cases of cholesteatoma. Residual polyposis can be reduced by a thorough surgical resection. The authors detail their present technique, which joins microsurgery, used to perform ethmoidectomy, with endoscopic surgery, employed to manoeuvre within the sphenoid and maxillary sinus, as well as to drain the frontal sinus, i.e. to treat areas out of the direct view. Moreover, patients are warned of the need for close postoperative controls which should always be performed through telescopes in order to secure a sound inspection of the surgical cavities. Any slight, incipient recurrence should be immediately resected in the office by means of endoscopic technique. Recurrent polyposis must be treated with the drug therapies now in use, a waiting complete elucidation of the pathogenic mechanism. Association with systemic diseases, such as asthma, may contraindicate major surgery, as it increases the recurrence expectancy. Simple polypectomy often attains the same result in these cases, that is temporary ventilation of the nasal fossae.
Download full-text PDF |
Source |
---|
J Clin Med
January 2025
Department of Surgical Oncology, Medical Faculty, Okan University, 34947 Istanbul, Turkey.
Childhood cancer survival rates have improved, but survivors face an increased risk of second malignant neoplasms (SMNs), particularly thyroid cancer. This study examines the demographic, clinical, genetic, and treatment characteristics of childhood cancer survivors who developed thyroid cancer as a second or third malignancy, emphasizing the importance of long-term surveillance. A retrospective review was conducted for childhood cancer survivors treated between 1990 and 2018 who later developed thyroid cancer as a second or third malignancy.
View Article and Find Full Text PDFAm J Clin Pathol
January 2025
Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, FL, US.
Objectives: Abdominal wall and intra-abdominal fibromatoses are locally aggressive, nonmetastasizing neoplasms. Surgery has been the mainstay of local control, but new forms of therapy have been developed that may influence the clinical course and morbidity. We studied the clinical features and outcomes of patients with abdominal and intra-abdominal fibromatoses over time.
View Article and Find Full Text PDFRhinology
December 2024
Department of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.
View Article and Find Full Text PDFIntroduction: When a pilot is referred for nasal polyposis, his/her flight fitness may be questionable. The objective of this retrospective study was to describe a case series of barotrauma in a pilot population exhibiting nasal polyposis and to discuss the decisions about their flight fitness.
Methods: There were 17 pilots with nasal polyposis who were referred to the Head and Neck Department of the National Pilot Expertise Center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!